Literature DB >> 11687447

Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children.

M R O'Gorman1, B DuChateau, M Paniagua, J Hunt, N Bensen, R Yogev.   

Abstract

The CD40 ligand (CD154), expressed primarily on activated CD4-positive T cells, is a costimulatory molecule involved in B-cell proliferation, germinal center formation, and immunoglobulin class switching. Since B-cell abnormalities including hypergammaglobulinemia and abnormal antibody-specific immune responses are prominent and occur early during the course of pediatric human immunodeficiency virus (HIV) infection, we measured the baseline levels and the induced levels of expression of CD154 on CD3(+) CD8(-) (T helper cells) in HIV-infected children and uninfected children born to HIV-positive mothers. The percentage of CD154(+) T helper cells activated in vitro and the level of CD154 expressed per T helper cell (mean fluorescent channel [MFC]) were significantly lower in the HIV-infected children than in the uninfected control group (77% +/- 3% versus 89% +/- 1%, respectively [P < 0.002], and 261 +/- 174 versus 415 +/- 130 MFC, respectively [P < 0.03]). The levels of CD154 expressed on resting T helper cells in the HIV-infected group were not significantly different from the levels observed in the control group. In the HIV-infected children, the level of CD154 on activated T helper cells correlated with the level of immunodeficiency, as assessed by the CD4 T-cell levels (correlation coefficient [r] = 0.707, P = 0.003), but did not correlate with the viral load or with any of the serum immunoglobulin concentrations measured in this group of HIV-infected children. The baseline level of CD154 expressed on T helper cells did, however, correlate with the concentration of immunoglobulin A in serum. We conclude that HIV-infected children have impaired regulation of CD154 expression which may contribute to the immune dysregulation commonly observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687447      PMCID: PMC96233          DOI: 10.1128/CDLI.8.6.1104-1109.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

Review 1.  The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells.

Authors:  M F Mackey; R J Barth; R J Noelle
Journal:  J Leukoc Biol       Date:  1998-04       Impact factor: 4.962

2.  Responses to measles immunization in children infected with human immunodeficiency virus.

Authors:  B J Rudy; R M Rutstein; J Pinto-Martin
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

3.  The ability of CD4+ cells from HIV+ individuals to express CD40 ligand after in vitro stimulation is not impaired.

Authors:  D Brugnoni; E Prati; P Airò; F Castelli; R Cattaneo
Journal:  Clin Immunol Immunopathol       Date:  1995-01

4.  Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.

Authors:  D Macchia; F Almerigogna; P Parronchi; A Ravina; E Maggi; S Romagnani
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

5.  CD40 ligand is functionally expressed on human eosinophils.

Authors:  J F Gauchat; S Henchoz; D Fattah; G Mazzei; J P Aubry; T Jomotte; L Dash; K Page; R Solari; D Aldebert
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

6.  The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

Authors:  M Roy; T Waldschmidt; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.

Authors:  R J Armitage; B M Macduff; M K Spriggs; W C Fanslow
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

9.  The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants.

Authors:  K L Kale; J C King; J J Farley; P E Vink; C O Cimino; P R Paradiso
Journal:  Pediatr Infect Dis J       Date:  1995-05       Impact factor: 2.129

10.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

Authors:  D Hollenbaugh; L S Grosmaire; C D Kullas; N J Chalupny; S Braesch-Andersen; R J Noelle; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  4 in total

1.  Persistently high IgA serum levels are a marker of immunological or virological failure of combined antiretroviral therapy in children with perinatal HIV-1 infection.

Authors:  Elena Chiappini; Luisa Galli; Pier-Angelo Tovo; Clara Gabiano; Maurizio de Martino
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

2.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

3.  Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.

Authors:  Norbert Donhauser; Kathrin Pritschet; Martin Helm; Thomas Harrer; Philipp Schuster; Moritz Ries; Georg Bischof; Jörg Vollmer; Sigrun Smola; Barbara Schmidt
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

4.  High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

Authors:  Laura Caggiari; Massimo Guidoboni; Emanuela Vaccher; Luigi Barzan; Giovanni Franchin; Annunziata Gloghini; Debora Martorelli; Paola Zancai; Maria Teresa Bortolin; Mario Mazzucato; Diego Serraino; Antonino Carbone; Paolo De Paoli; Riccardo Dolcetti
Journal:  Infect Agent Cancer       Date:  2007-03-01       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.